EKİNCİ, F. Et Al. 2022. Inflammatory Prognostic Index in Metastatic Renal Carcinoma Treated with Nivolumab. Journal of the College of Physicians and Surgeons Pakistan , vol.32, no.10 , 1288-1294.

EKİNCİ, F., ERDOĞAN, A. P., Yildirim, S., Bulut, G., Yilmaz, C., & Barutca, S., (2022). Inflammatory Prognostic Index in Metastatic Renal Carcinoma Treated with Nivolumab. Journal of the College of Physicians and Surgeons Pakistan , vol.32, no.10, 1288-1294.

EKİNCİ, FERHAT Et Al. "Inflammatory Prognostic Index in Metastatic Renal Carcinoma Treated with Nivolumab," Journal of the College of Physicians and Surgeons Pakistan , vol.32, no.10, 1288-1294, 2022

EKİNCİ, FERHAT Et Al. "Inflammatory Prognostic Index in Metastatic Renal Carcinoma Treated with Nivolumab." Journal of the College of Physicians and Surgeons Pakistan , vol.32, no.10, pp.1288-1294, 2022

EKİNCİ, F. Et Al. (2022) . "Inflammatory Prognostic Index in Metastatic Renal Carcinoma Treated with Nivolumab." Journal of the College of Physicians and Surgeons Pakistan , vol.32, no.10, pp.1288-1294.

@article{article, author={FERHAT EKİNCİ Et Al. }, title={Inflammatory Prognostic Index in Metastatic Renal Carcinoma Treated with Nivolumab}, journal={Journal of the College of Physicians and Surgeons Pakistan}, year=2022, pages={1288-1294} }